Trials / Sponsors / Wex Pharmaceuticals Inc.
Wex Pharmaceuticals Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodo Chemotherapy-induced Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy | Phase 2 | 2022-04-19 |
| Completed | A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate TQT Study | Phase 1 | 2018-02-07 |
| Terminated | The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resultin Pain, Peripheral Neuropathy, Neuropathic Pain | Phase 2 | 2012-07-01 |
| Completed | Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Voluntee Healthy | Phase 1 | 2011-12-01 |
| Completed | Tetrodotoxin Open-label Efficacy and Safety Continuation Study Pain, Cancer | Phase 3 | 2008-07-01 |
| Completed | Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-rel Pain, Cancer | Phase 3 | 2008-04-01 |